BPC 157: Experimental Peptide Creates Risk for Athletes Why Are People Injecting Themselves with Peptides? The New Yorker Is BPC 157 Legal? Understanding Its Status and Implications When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The FDA will hold a meeting to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular among wellness influencers, fitness gurus On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval.